Japan’s general trading houses are steadily becoming a force to be reckoned with in the pharmaceutical industry — and not…
COLUMN
Seven Recruitment Trends in 2023
As the post-pandemic world of work continues to evolve, so do recruiters’ strategies and tools for finding and engaging top talent. In 2023, we are seeing these seven trends: 1. Employer branding is becoming an increasingly important factor in the…
To read the full story
COLUMN
- The Unseen Edge & the Shadow of Bias: Awareness as the Cornerstone of Leadership Success
October 31, 2025
- The Keen Eye: Awareness as a Leadership Cornerstone
September 29, 2025
- A “50-Billion-Yen Plus” Newcomer
September 4, 2025
- AI in Japanese Pharma: Now, Not Later!
August 29, 2025
- Beyond the Bench: Why Biopharma Needs Strategic Thinkers
July 28, 2025
A public-private council report outlining industry views on Japan’s drug pricing systems drew little discussion at a meeting of the…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…